In this study, we did not detect any statistically significant difference in the proportion of NKG2C+ cells among either total T cells or CD56− and CD56+ T cell subsets between healthy donors, COVID-19 patients, and convalescents (Figure S4). The gene discussed is NCAM1; the disease is COVID-19.